OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

Clinical trial NCT06355934 · RECRUITING

Trial details

NCT number: NCT06355934
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

ATTR Amyloidosis

Start date: 2023-08-21
Primary completion: 2026-11-02
Enrollment: 52121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.